A variety of autoimmune diseases have a ‘preclinical’ period of development where blood or other tests can show abnormalities in the immune system sometimes years prior to someone feeling ‘sick’. Dr. Deane’s research is focused primarily on the preclinical rheumatoid arthritis (RA). Dr. Deane is currently a principal or co-investigator in several multi-centered studies investigating how genetics and environmental factors influence the early development of RA. He also has special interests in the role of the lung and other mucosal sites in the development of RA. Dr. Deane is also the Principal Investigator on an NIH-sponsored clinical trial for the prevention of RA that is entitled ‘Strategy for the Prevention of RA, or 'StopRA'.
1987-1992: B.A. History University of California, Davis and Newbold College, Bracknell, Great Britain
1993-1997: M.D., Loma Linda University School of Medicine, Loma Linda, California
1997-2000: Intern and Resident, Internal Medicine, University of Colorado School of Medicine, Denver, Colorado
2001-2004: Fellow, Division of Rheumatology, University of Colorado School of Medicine, Denver, Colorado
2002-2011: Ph.D. Clinical Science, University of Colorado, School of Medicine, Aurora, CO
Rheumatoid arthritis is a chronic, inflammatory condition that primarily targets the joints, causing joint stiffness, swelling, and pain.
7515 Main Street, Suite 195,
Houston, Texas 77030,
Monday to Friday 8am - 6pm
imaware™ provides laboratory testing for wellness monitoring, informational, and educational use.
*Our tests are not intended to diagnose any conditions - only your healthcare provider can make that determination.